Enanta Pharmaceuticals Inc. Stock
Enanta Pharmaceuticals Inc. gained 0.900% compared to yesterday.
Enanta Pharmaceuticals Inc. is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
With a target price of 17 € there is a hugely positive potential of 51.79% for Enanta Pharmaceuticals Inc. compared to the current price of 11.2 €.
So far the community has only identified positive things for Enanta Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Enanta Pharmaceuticals Inc. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enanta Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enanta Pharmaceuticals Inc. | 0.900% | -5.263% | -15.625% | 56.522% | -20.588% | -34.146% | -69.318% |
| Evolus Inc | -0.040% | -0.954% | -14.526% | -33.462% | -4.771% | -42.967% | -41.356% |
| Heron Therapeutics Inc. | 1.530% | 3.155% | 15.773% | -72.386% | -61.257% | -69.171% | -95.838% |
| Rhythm Pharmaceuticals | -1.080% | 1.667% | -5.181% | 26.207% | -2.139% | 479.114% | 535.417% |
Comments
Enanta Pharmaceuticals (ENTA) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ENTA provided by MarketBeat
Enanta Pharmaceuticals (ENTA) is now covered by Rodman & Renshaw. They set a "buy" rating and a $20.00 price target on the stock.
Show more
Ratings data for ENTA provided by MarketBeat
Enanta Pharmaceuticals (NASDAQ:ENTA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ENTA provided by MarketBeat